Patricia W.C. Bosman

Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference

Somayya Noori, Christie P.M. Verkleij, Marina Zajec et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2021 · 24 citations · Full text

Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

Kristine A. Frerichs, Patricia W.C. Bosman, Inger S. Nijhof et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 22 citations · Full text

CD38-targeted therapy with daratumumab reduces autoantibody levels in multiple myeloma patients

Kristine A. Frerichs, Christie P.M. Verkleij, Patricia W.C. Bosman et al. · Journal of Translational Autoimmunity · 2019 · 20 citations · Full text

Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step‐up dosing

Charlotte L.B.M. Korst, K. Groen, Patricia W.C. Bosman et al. · HemaSphere · 2024 · 18 citations · Full text

Clinical Immunology, Recurrent Crs, Immunology +23

Efficacy and Safety of Nivolumab Combined with Daratumumab with or without Low-Dose Cyclophosphamide in Relapsed/Refractory Multiple Myeloma; Interim Analysis of the Phase 2 Nivo-Dara Study

Christie P.M. Verkleij, Monique C. Minnema, Okke de Weerdt et al. · Blood · 2019 · 12 citations